Diagnosis-Driven Targeted Therapy in Acute Myeloid Leukemia: Clinical Integration of Tyrosine Kinase, BCL-2, and CD33-Directed Strategies with Midostaurin, Venetoclax, and Gemtuzumab Ozogamicin.
Saved in:
| Title: | Diagnosis-Driven Targeted Therapy in Acute Myeloid Leukemia: Clinical Integration of Tyrosine Kinase, BCL-2, and CD33-Directed Strategies with Midostaurin, Venetoclax, and Gemtuzumab Ozogamicin. |
|---|---|
| Authors: | Kawczak, Piotr1 (AUTHOR) piotr.kawczak@gumed.edu.pl, Kawczak, Katarzyna2 (AUTHOR), Bączek, Tomasz1,3 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Jul2026, Vol. 15 Issue 13, p4886. 43p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
